The stock market is expected to be in focus this week as investors assess the outlook for the economy, inflation, interest rates, and corporate earnings. The major averages saw sharp gains last Friday, driven by hopes for a de-escalation of the U.S.-China trade war.
Wall Street’s first quarter earnings season hits full swing, with four of the massive ‘Magnificent Seven’ tech stocks set to report their latest results. Meta Platforms is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock pick for Q1.
As InvestingPro points out, Meta boasts a “GREAT” Financial Health Overall Score of 3.22, with particularly strong metrics in Profit (4.49) and Cash Flow (3.74). Analysts are overwhelmingly bullish on Meta, with a Strong Buy consensus recommendation (1.48) and a mean price target of $713.63, suggesting upside potential of 30.4% from current levels.
On the opposite end of the spectrum, Pfizer is bracing for the release of its Q1 financial results, which are expected to be negatively impacted by declining demand for COVID-19 products and increased competition in its non-COVID portfolio. Market participants expect a possible implied move of 4% in either direction in PFE stock after the print drops.
Investors looking to position their portfolios one step ahead can leverage InvestingPro’s market-beating features, including ProPicks AI, InvestingPro Fair Value, Advanced Stock Screener, and Top Ideas. Don’t miss out on this opportunity to unlock investment opportunities while minimizing risks.
Source: https://finance.yahoo.com/news/1-stock-buy-1-stock-132043391.html